Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters











Database
Language
Publication year range
1.
Molecules ; 27(4)2022 Feb 10.
Article in English | MEDLINE | ID: mdl-35208983

ABSTRACT

Social insects are in mutualism with microorganisms, contributing to their resistance against infectious diseases. The fungus Pseudallescheria boydii SNB-CN85 isolated from termites produces ovalicin derivatives resulting from the esterification of the less hindered site of the ovalicin epoxide by long-chain fatty acids. Their structures were elucidated using spectroscopic analysis and semisynthesis from ovalicin. For ovalicin, these compounds displayed antiprotozoal activities against Plasmodium falciparum and Trypanosoma brucei, with IC50 values of 19.8 and 1.1 µM, respectively, for the most active compound, i.e., ovalicin linoleate. In parallel, metabolomic profiling of a collection of P. boydii strains associated with termites made it possible to highlight this class of compounds together with tyroscherin derivatives in all strains. Finally, the complete genome of P. boydii strains was obtained by sequencing, and the cluster of potential ovalicin and ovalicin biosynthesis genes was annotated. Through these metabolomic and genomic analyses, a new ovalicin derivative named boyden C, in which the 6-membered ring of ovalicin was opened by oxidative cleavage, was isolated and structurally characterized.


Subject(s)
Antimalarials , Isoptera/microbiology , Plasmodium falciparum/growth & development , Scedosporium , Sesquiterpenes , Trypanocidal Agents , Trypanosoma brucei brucei/growth & development , Animals , Antimalarials/chemistry , Antimalarials/pharmacology , French Guiana , Scedosporium/chemistry , Scedosporium/metabolism , Sesquiterpenes/chemistry , Sesquiterpenes/pharmacology , Trypanocidal Agents/chemistry , Trypanocidal Agents/pharmacology
2.
Med Mycol ; 59(5): 441-452, 2021 May 04.
Article in English | MEDLINE | ID: mdl-32766889

ABSTRACT

The genus Scedosporium is composed of clinically relevant fungal species, such as Scedosporium aurantiacum, Scedosporium apiospermum, and Scedosporium boydii. Surface molecules have been described that play crucial roles in fungi-macrophage interaction, and many of them are pathogen-associated molecular patterns (PAMPs). The present study aims to characterize peptidoglycans obtained from Scedosporium aurantiacum and Scedosporium minutisporum, a clinical and an environmental isolate, respectively, and compare their roles in pathogen-host interaction. Both molecules were characterized as peptidorhamnomannans (PRMs), similar to what has been already described for other Scedosporium species. Rabbit immune sera obtained by injecting whole cells from each species recognized both fungal cells and purified PRMs, suggesting that a cross-reaction occur between both fungi. Immunofluorescent microscopy revealed that PRMs are exposed on fungal surface. Prior incubation of purified molecules with immune sera before adding to cells led to loss of fluorescent, indicating that PRM is a major molecule recognized by immune sera. Fungi-macrophage interaction revealed that S. aurantiacum is able to survive more inside phagocytic cells than S. minutisporum, and PRM from both fungi plays a role in phagocytosis when the purified molecule is pre-incubated with macrophage. In addition, PRM induce nitric oxide release by macrophages. Our data indicate that PRM is an important PAMP exposed on fungal surface with the potential of immune modulation.


In this work, peptidorhamnomannans from Scedosporium aurantiacum and Scedosporium minutisporum have been characterized. These molecules play important roles in phagocytosis and oxidative burst in peritoneal macrophages and are recognized by immune sera.


Subject(s)
Glycoproteins/chemistry , Glycoproteins/physiology , Macrophages/metabolism , Macrophages/microbiology , Scedosporium/metabolism , Animals , Antibodies, Fungal/chemistry , Antibodies, Fungal/immunology , Female , Host Microbial Interactions , Humans , Invasive Fungal Infections/immunology , Invasive Fungal Infections/microbiology , Mice , Mice, Inbred BALB C , Nitric Oxide/metabolism , Pathogen-Associated Molecular Pattern Molecules/metabolism , Phagocytosis , Rabbits
3.
BMC Microbiol ; 20(1): 245, 2020 08 06.
Article in English | MEDLINE | ID: mdl-32762645

ABSTRACT

BACKGROUND: Peptidorhamnomannan is a glycoconjugate that consists of a peptide chain substituted by O- and N-linked glycans, present on the cell surface of Lomentospora prolificans, a saprophytic fungus which is widely distributed in regions with temperate climates. O-linked oligosaccharides from peptidorhamnomannan isolated from Lomentospora prolificans conidia are recognized by macrophages mediating macrophage - conidia interaction. In this work, peptidorhamnomannan was isolated from L. prolificans mycelium cell wall and its role in macrophage - Candida albicans interaction was evaluated. RESULTS: Purified peptidorhamnomannan inhibits the reactivity of rabbit immune sera to mycelial and conidia forms of L. prolificans, indicating that this glycoconjugate is exposed on the fungal surface and can mediate interaction with host immune cells. We demonstrated that peptidorhamnomannan leads to TNF-α production in J774 macrophages for 1, 2 and 3 h of incubation, suggesting that this glycoconjugate may have a beneficial role in the response to fungal infections. In order to confirm this possibility, the effect of peptidorhamnomannan on the macrophage - C. albicans interaction was evaluated. Macrophages treated with peptidorhamnomannan led to a lower fungal survival, suggesting that peptidorhamnomannan induces an increased fungicidal activity in macrophages. Furthermore, TNF-α levels were measured in supernatants after macrophage - C. albicans interaction for 1, 2 and 3 h. Peptidorhamnomannan treatment led to a higher TNF-α production at the beginning of the interaction. However, the release of TNF-α was not maintained after 1 h of incubation. Besides, peptidorhamnomannan did not show any inhibitory or fungicidal effect in C. albicans when used at 100 µg/ml but it was able to kill C. albicans at a concentration of 400 µg/ml. CONCLUSION: We suggest that peptidorhamnomannan acts as a molecular pattern on the invading pathogen, promotes TNF-α production and, thus, increases macrophage fungicidal activity against Candida albicans.


Subject(s)
Candida albicans/immunology , Glycoproteins/pharmacology , Macrophages/cytology , Scedosporium/metabolism , Animals , Candida albicans/pathogenicity , Cell Line , Cell Wall/metabolism , Gene Expression Regulation/drug effects , Immune Sera/drug effects , Immune Sera/metabolism , Macrophages/drug effects , Macrophages/immunology , Macrophages/microbiology , Mice , Mycelium/metabolism , Phagocytosis , Rabbits , Tumor Necrosis Factor-alpha/metabolism
4.
Biofouling ; 36(3): 308-318, 2020 03.
Article in English | MEDLINE | ID: mdl-32401558

ABSTRACT

In the present study, the composition of the extracellular matrix (ECM) of the biofilm formed by Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans on a polystyrene surface was investigated. Confocal laser scanning microscopy revealed a dense mycelial mass, with an ECM covering/interspersing the fungal cells and containing carbohydrate-rich molecules (e.g. glycoproteins) and extracellular DNA. The ECMs that were chemically extracted from mature biofilms formed by each of these fungi was predominantly composed of polysaccharides, followed by proteins, nucleic acids and sterols. In general, the amount of biofilm ECM was significantly greater in S. minutisporum and S. aurantiacum than in S. apiospermum and L. prolificans. Corroborating these results, the disarticulation of mature biofilms with enzymes, sodium metaperiodate and chelating agents occurred mainly in S. minutisporum and S. aurantiacum. Collectively, these results have revealed for the first time the composition of the ECM of the biofilms formed by Scedosporium/Lomentospora species and the role it plays in their architecture.


Subject(s)
Ascomycota/growth & development , Biofilms/growth & development , Extracellular Matrix/metabolism , Scedosporium/growth & development , Ascomycota/metabolism , Humans , Microscopy, Confocal , Polystyrenes/chemistry , Scedosporium/metabolism , Surface Properties
5.
Future Med Chem ; 11(22): 2905-2917, 2019 11.
Article in English | MEDLINE | ID: mdl-31713454

ABSTRACT

Aim: Glycosphingolipids are conserved lipids displaying a variety of functions in fungal cells, such as determination of cell polarity and virulence. They have been considered as potent targets for new antifungal drugs. The present work aimed to test two inhibitors, myriocin and DL-threo-1-Phenyl-2-palmitoylamino-3-morpholino-1-propanol, in Scedosporium boydii, a pathogenic fungus which causes a wide range of disease. Materials & methods: Mass spectrometry, microscopy and cell biology approaches showed that treatment with both inhibitors led to defects in fungal growth and membrane integrity, and caused an increased susceptibility to the current antifungal agents. Conclusion: These data demonstrate the antifungal potential of drugs inhibiting sphingolipid biosynthesis, as well as the usefulness of sphingolipids as promising targets for the development of new therapeutic options.


Subject(s)
Biofilms/growth & development , Scedosporium/metabolism , Sphingolipids/biosynthesis , Cell Membrane/metabolism , Fatty Acids, Monounsaturated/metabolism , Meperidine/analogs & derivatives , Meperidine/metabolism
6.
Fungal Biol ; 120(2): 166-72, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26781373

ABSTRACT

Glucosylceramides (GlcCer) are the main neutral glycosphingolipids expressed in fungal cells. In this work, glucosylceramides (GlcCer) were extracted from three strains of Scedosporium (Pseudallescheria) boydii, one strain of Pseudallescheria ellipsoidea and one strain of Pseudallescheria angusta and purified by several chromatographic steps. Using high-performance thin layer chromatography (HPTLC), we found a similarity between GlcCer obtained from all of the analysed strains. A detailed structural analysis of the P. ellipsoidea GlcCer was performed via electrospray ionization mass spectrometry (ESI-MS) and confirmed in 1- and 2-D heteronuclear NMR experiments ((1)H-(13) C HSQC). GlcCer species produced by mycelial forms of these strains displayed the same structure previously demonstrated by our group for P. boydii, Cryptococcus neoformans, Pseudallescheria minustipora, Fusarium solani, and Colletotrichum gloesporioides. A monoclonal antibody (mAb) against GlcCer was used for immunofluorescence experiments. Our results revealed that GlcCer is present on the surface of these fungi, and no difference was observed in the GlcCer structure of the present set of strains in terms of geographic or clinical origin, suggesting a conserved GlcCer structure similar to those previously described for Scedosporium apiospermum, Scedosporium aurantiacum, and P. minutispora. The surface distribution of GlcCer in these fungi is suggestive of the involvement of this molecule in fungal growth.


Subject(s)
Glucosylceramides/chemistry , Mycoses/microbiology , Pseudallescheria/metabolism , Scedosporium/metabolism , Glucosylceramides/metabolism , Humans , Molecular Structure , Pseudallescheria/chemistry , Pseudallescheria/isolation & purification , Scedosporium/chemistry , Scedosporium/isolation & purification , Spectrometry, Mass, Electrospray Ionization
7.
PLoS One ; 9(5): e98149, 2014.
Article in English | MEDLINE | ID: mdl-24878570

ABSTRACT

Scedosporium apiospermum is an emerging fungal pathogen that causes both localized and disseminated infections in immunocompromised patients. Glucosylceramides (CMH, GlcCer) are the main neutral glycosphingolipids expressed in fungal cells. In this study, glucosylceramides (GlcCer) were extracted and purified in several chromatographic steps. Using high-performance thin layer chromatography (HPTLC) and electrospray ionization mass spectrometry (ESI-MS), N-2'-hydroxyhexadecanoyl-1-ß-D-glucopyranosyl-9-methyl-4,8-sphingadienine was identified as the main GlcCer in S. apiospermum. A monoclonal antibody (Mab) against this molecule was used for indirect immunofluorescence experiments, which revealed that this CMH is present on the surface of the mycelial and conidial forms of S. apiospermum. Treatment of S. apiospermum conidia with the Mab significantly reduced fungal growth. In addition, the Mab also enhanced the phagocytosis and killing of S. apiospermum by murine cells. In vitro assays were performed to evaluate the CMHs for their cytotoxic activities against the mammalian cell lines L.929 and RAW, and an inhibitory effect on cell proliferation was observed. Synergistic in vitro interactions were observed between the Mab against GlcCer and both amphotericin B (AmB) and itraconazole. Because Scedosporium species develop drug resistance, the number of available antifungal drugs is limited; our data indicate that combining immunotherapy with the available drugs might be a viable treatment option. These results suggest that in S. apiospermum, GlcCer are most likely cell wall components that are targeted by antifungal antibodies, which directly inhibit fungal development and enhance macrophage function; furthermore, these results suggest the combined use of monoclonal antibodies against GlcCer and antifungal drugs for antifungal immunotherapy.


Subject(s)
Glucosylceramides/metabolism , Macrophages/microbiology , Scedosporium/growth & development , Scedosporium/metabolism , Amphotericin B/pharmacology , Animals , Antibodies, Monoclonal/immunology , Cell Line , Culture Media, Conditioned/metabolism , Glucosylceramides/chemistry , Glucosylceramides/immunology , Itraconazole/pharmacology , Male , Mice , Scedosporium/drug effects , Scedosporium/physiology
8.
Res Microbiol ; 157(5): 425-32, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16487686

ABSTRACT

Pseudallescheria boydii is an opportunistic filamentous fungus that causes serious infections in humans. Virulence attributes expressed by P. boydii are unknown. Conversely, peptidases are incriminated as virulence factors in several pathogenic fungi. Here we investigated the extracellular peptidase profile in P. boydii. After growth on Sabouraud for 7 days, mycelia of P. boydii were incubated for 20 h in PBS-glucose. The cell-free PBS-glucose supernatant was submitted to SDS-PAGE and 12 secretory polypeptides were observed. Two of these polypeptides (28 and 35 kD) presented proteolytic activity when BSA was used as a copolymerized substrate. The extracellular peptidases were most active in acidic pH (5.5) and fully inhibited by 1,10-phenanthroline, a zinc-metallopeptidase inhibitor. Other metallo-, cysteine, serine and aspartic proteolytic inhibitors did not significantly alter these activities. To confirm that these enzymes belong to the metallo-type peptidases, the apoenzymes were obtained by dialysis against chelating agents, and supplementation with different cations, especially Cu(2+) and Zn(2+), restored their activities. Except for gelatin, both metallopeptidases hydrolyzed various co-polymerized substrates, including human serum albumin, casein, hemoglobin and IgG. Additionally, the metallopeptidases were able to cleave different soluble proteinaceous substrates such as extracellular matrix components and sialylated proteins. All these hydrolyses were inhibited by 1,10-phenanthroline. Interestingly, Scedosporium apiospermum (the anamorph of P. boydii) produced a distinct extracellular peptidase profile. Collectively, our results demonstrated for the first time the expression of acidic extracellular metallopeptidases in P. boydii capable of degrading several proteinaceous compounds that could help the fungus to escape from natural human barriers and defenses.


Subject(s)
Fungal Proteins/metabolism , Metalloproteases/metabolism , Peptides/metabolism , Proteins/metabolism , Pseudallescheria/metabolism , Caseins/metabolism , Fungal Proteins/antagonists & inhibitors , Fungal Proteins/biosynthesis , Fungal Proteins/chemistry , Hemoglobins/metabolism , Humans , Immunoglobulin G/metabolism , Metalloproteases/antagonists & inhibitors , Metalloproteases/biosynthesis , Metalloproteases/chemistry , Molecular Weight , Mycetoma/metabolism , Mycetoma/microbiology , Peptide Biosynthesis , Peptides/antagonists & inhibitors , Peptides/chemistry , Phenanthrolines/pharmacology , Scedosporium/metabolism , Serum Albumin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL